0
Your Cart
Item(s)
Qty
Price

No items in your cart

Picture of Advertisement, Poster, Head, Person, Face, Photography, Portrait with text The Impact of ...
The Impact of Vulvovaginal Atrophy on Sexual Health and Quality of Life at Postmenopause
05/21/2025

This paper dives into how vulvovaginal atrophy (VVA) — the thinning, drying, and inflammation of the vaginal walls due to estrogen loss — affects postmenopausal women. The authors review both clinical findings and large patient surveys, analyzing how widespread and disruptive VVA really is.

Who was involved:

The study is a literature review by European menopause specialists and gynecologists, combining findings from observational studies, cross-sectional surveys, and clinical trials. It didn’t test new treatments but focused on interpreting real-world data.

What they found:

  • VVA affects up to 50–70% of postmenopausal women, yet most never bring it up with their doctor.
  • Symptoms — like vaginal dryness, irritation, and painful sex — don’t usually improve without treatment and can progressively worsen.
  • The condition impacts more than just sex; it reduces quality of life, sleep, confidence, and intimate relationships.
  • Despite effective treatments (like local estrogen therapy), underdiagnosis is common because women either normalize their symptoms or feel embarrassed to seek help.

Why it matters:
VVA isn’t a “nuisance” issue — it’s a chronic, under-discussed medical condition with a profound impact on well-being. This paper encourages clinicians to proactively ask patients about symptoms and guide them toward treatment.

Link: PubMed Abstract